BeyondSpring is trading 5.73% up at $0.76, with the move appearing mainly linked to stronger biotech-sector sentiment following positive Moderna cancer-vaccine trial results.
- No new company-specific announcement was identified for August 20, 2026.
- Biotech ETF XBI is up 3.73%.
- The August 14 earnings release remains the latest major update, citing clinical progress, cash of $6.5 million, and continued losses.